Clinical Trials on Monoclonal Gammopathy of Undetermined Significance

Total 96 results





    • NCT04439006
      Recruiting
      Conditions: Aplastic Anemia; Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Monoclonal B-Cell Lymphocytosis; Monoclonal Gammopathy of Undetermined Significance; Myelodysplastic Syndrome; Symptomatic COVID-19 Infection Laboratory-Confirmed
    • NCT04213274
      Not yet recruiting
      Conditions: Schnitzler Syndrome; Urticarial Vasculitis With Monoclonal Immunoglobulin M Component, Schnitzler (Disorder)
    • NCT04114084
      Recruiting
      Conditions: Multiple Myeloma; Monoclonal Gammopathy of Undetermined Significance
    • NCT04023747
      Recruiting
      Conditions: Pre-cancerous Lymphoproliferative Disorders
    • NCT03951220
      Recruiting
      Conditions: Myeloma; Monoclonal Gammopathy of Undetermined Significance (MGUS); Smouldering Myeloma
    • NCT03855878
      Recruiting
      Conditions: Monoclonal Gammopathy of Undetermined Significance
    • NCT03832140
      Completed
      Conditions: Pruritus; Monoclonal Gammopathy
    • NCT03820817
      Recruiting
      Conditions: IgA Monoclonal Gammopathy; IgG Monoclonal Gammopathy; IgM Monoclonal Gammopathy; Light Chain Deposition Disease; Monoclonal Gammopathy; Smoldering Waldenstrom Macroglobulinemia; Waldenstrom Macroglobulinemia; Gammopathy, Monoclonal; Gammopathy Igg
    • NCT03717844
      Recruiting
      Conditions: Multiple Myeloma; Amyloidosis; Cryoglobulinemia; Castleman's Disease; Light Chain Deposition Disease; Heavy Chain Deposition Disease; Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes; Smoldering Multiple Myeloma; Plasma Cell Leukemia
    • NCT03629561
      Recruiting
      Conditions: Monoclonal Gammopathy of Renal Significance
    • NCT03616483
      Recruiting
      Conditions: Plasma Cell Dyscrasias
    • NCT03595371
      Recruiting
      Conditions: Schnitzler Syndrome
    • NCT03591614
      Not yet recruiting
      Conditions: Monoclonal Gammopathy; Smoldering Myeloma; Myeloma
    • NCT03521596
      Recruiting
      Conditions: Waldenstrom Macroglobulinemia
    • NCT03327597
      Active, not recruiting
      Conditions: Monoclonal Gammopathy of Undetermined Significance
    • NCT03236428
      Active, not recruiting
      Conditions: Monoclonal Gammopathy; Smoldering Multiple Myeloma
    • NCT03095118
      Active, not recruiting
      Conditions: Membranoproliferative Glomerulonephritis
    • NCT03046381
      Completed
      Conditions: Schnitzler's Syndrome
    • NCT02933021
      Active, not recruiting
      Conditions: Monoclonal Gammopathy of Unknown Significance
    • NCT02920190
      Withdrawn
      Conditions: Monoclonal Gammopathies; Overweight; Obesity
    • NCT02741999
      Completed
      Conditions: Plasma Cell Dyscrasia; Monoclonal Gammopathy
    • NCT02726750
      Recruiting
      Conditions: Monoclonal Gammopathy of Unknown Significance; Smoldering Multiple Myeloma
    • NCT02298816
      Enrolling by invitation
      Conditions: Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Waldenstrom Macroglobulinemia; Lymphocytosis; Lymphoma, Non-Hodgkin; B-Cell Chronic Lymphocytic Leukemia; Hematological Malignancies
    • NCT02269592
      Recruiting
      Conditions: Monoclonal Gammopathy of Undetermined Significance (MGUS); Chronic Lymphocytic Leukemia (CLL); Myelodysplastic-Myeloproliferative Diseases; Hematological Malignancies; B-cell Malignancy, Low-grade; Myelodysplastic Syndrome With Low-grade Lesions; IgG Monoclonal Gammopathy of Uncertain Significance; Smoldering Multiple Myeloma; Waldenstrom Macroglobulinemia
    • NCT02033928
      Completed
      Conditions: Myeloma, Multiple; Paraproteinemias; Hematologic Neoplasms
    • NCT01955395
      Completed
      Conditions: Monoclonal Gammopathy of Undetermined Significance; Smoldering Multiple Myeloma
    • NCT01588015
      Active, not recruiting
      Conditions: Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Promyelocytic Leukemia (M3); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma; Anaplastic Large Cell Lymphoma; B-cell Adult Acute Lymphoblastic Leukemia; Chronic Eosinophilic Leukemia; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cytomegalovirus Infection; de Novo Myelodysplastic Syndromes; Essential Thrombocythemia; Extramedullary Plasmacytoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Isolated Plasmacytoma of Bone; Monoclonal Gammopathy of Undetermined Significance; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Peripheral T-cell Lymphoma; Polycythemia Vera; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Primary Central Nervous System Hodgkin Lymphoma; Primary Central Nervous System Non-Hodgkin Lymphoma; Primary Myelofibrosis; Progressive Hairy Cell Leukemia, Initial Treatment; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Multiple Myeloma; Stage I Small Lymphocytic Lymphoma; Stage IA Mycosis Fungoides/Sezary Syndrome; Stage IB Mycosis Fungoides/Sezary Syndrome; Stage II Adult Hodgkin Lymphoma; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Multiple Myeloma; Stage IIA Mycosis Fungoides/Sezary Syndrome; Stage IIB Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Multiple Myeloma; Stage III Small Lymphocytic Lymphoma; Stage IIIA Mycosis Fungoides/Sezary Syndrome; Stage IIIB Mycosis Fungoides/Sezary Syndrome; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Small Lymphocytic Lymphoma; Stage IVA Mycosis Fungoides/Sezary Syndrome; Stage IVB Mycosis Fungoides/Sezary Syndrome; T-cell Adult Acute Lymphoblastic Leukemia; T-cell Large Granular Lymphocyte Leukemia; Untreated Adult Acute Myeloid Leukemia; Untreated Hairy Cell Leukemia; Waldenström Macroglobulinemia
    • NCT01571726
      Withdrawn
      Conditions: Multiple Myeloma; Smoldering Multiple Myeloma; Monoclonal Gammopathy of Undetermined Significance
    • NCT01548573
      Terminated
      Conditions: Multiple Myeloma
    • NCT01543100
      Completed
      Conditions: Monoclonal Gammopathy; Monoclonal Gammopathy of Undetermined Signification; Myeloma
    • NCT01408225
      Recruiting
      Conditions: Plasma Cell Dyscrasias; Monoclonal Gammopathy of Undetermined Significance; AL Amyloidosis; Multiple Myeloma
    • NCT01390350
      Completed
      Conditions: Schnitzler Syndrome
    • NCT01276522
      Completed
      Conditions: Schnitzler Syndrome
    • NCT01245127
      Completed
      Conditions: Schnitzler Syndrome
    • NCT01237054
      Completed
      Conditions: Multiple Myeloma; Smoldering Multiple Myeloma; Monoclonal Gammopathy of Undetermined Significance
    • NCT01219010
      Completed
      Conditions: Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Plasma Cell Neoplasm
    • NCT01210716
      Completed
      Conditions: Autoimmune Diseases; Renal Disorders; Hematologic Disorders; Oncologic Disorders
    • NCT01109407
      Completed
      Conditions: Smoldering Myeloma; Monoclonal Gammopathy of Undetermined Significance
    • NCT01079429
      Active, not recruiting
      Conditions: Monoclonal Gammopathy of Undetermined Significance; Smoldering Myeloma
    • NCT01063907
      Completed
      Conditions: Multiple Myeloma
    • NCT01045772
      Completed
      Conditions: Muckle-Wells Syndrome; Schnitzler Syndrome
    • NCT00942422
      Terminated
      Conditions: Multiple Myeloma and Plasma Cell Neoplasm; Precancerous Condition
    • NCT00933296
      Completed
      Conditions: Schnitzler Syndrome
    • NCT00919139
      Completed
      Conditions: Multiple Myeloma; Smoldering Myeloma; Waldenstrom's Macroglobulinemia; Monoclonal Gammopathy of Undetermined Significance; Amyloidosis
    • NCT00898066
      Completed
      Conditions: Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Precancerous/Nonmalignant Condition
    • NCT00899353
      Terminated
      Conditions: Monoclonal Gammopathy of Undetermined Significance; Smoldering Multiple Myeloma; Chronic Lymphocytic Leukemia
    • NCT00899665
      Completed
      Conditions: Anemia; Metastatic Cancer; Myelodysplastic Syndromes; Precancerous Condition; Prostate Cancer
    • NCT00899951
      Terminated
      Conditions: Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Pain; Precancerous Condition; Unspecified Adult Solid Tumor, Protocol Specific
    • NCT00900263
      Completed
      Conditions: Multiple Myeloma; Plasma Cell Myeloma; Precancerous Condition
    • NCT00726830
      Terminated
      Conditions: Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Pain; Precancerous Condition; Unspecified Adult Solid Tumor, Protocol Specific